In a historic move, the FDA is deploying generative AI across all its centers to speed up the drug review process
The AI Innovator
An opinion piece by the founder and CEO of Baya Systems
A new generation of agents will acquire superhuman capabilities by learning predominantly from experience.
An opinion piece from the CTO of Gupshup, a leading conversational AI platform
An opinion piece from the research scientist of the ETS Research Institute